Life sciences venture capital firm RiverVest Venture Partners announced the creation of the $80 million RiverVest Venture Fund III at $80.2 million. "This is a great time to be investing in drugs and therapeutic medical devices," said RiverVest Managing Director Jay Schmelter. "There are many attractively valued investment opportunities in our space right now." The fund has already invested in three companies and is looking for more investments. More